BioWorld

April 7, 2008

View Archived Issues

Avant Gets $11.5M Payday with FDA OK of Rotarix

Avant Immunotherapeutics Inc. will see an additional $11.5 million in milestone payments for the rotavirus vaccine Rotarix, now that it has been FDA-approved. (BioWorld Today) Read More

Deerfield Deal Secures $30M for Vivus' Avanafil Phase III Trials

Read More

Mitochondrial DNA Plays Role in Predilection to Metastasize

Read More

House OKs $50B HIV Bill, Senators Gearing for a Fight

Read More

Abraxis Buys 2 Companies, Gets Cyclodextrin Platform

Read More

Other News To Note

Read More

Clinic Roundup

Read More